Celldex Therapeutics CLDX, +17.49% shares jumped more than 30% premarket on Monday after the company released positive clinical trial results for its lead asset
The well-known personal-finance expert, Suze Orman, was recently interviewed by Mike Wallace, and she didn’t mince words. When Wallace sheepishly admitted that he leases
Shares of Canadian cannabis company Organigram Holdings Inc. soared 30% Monday, after the company said it is getting a fresh C$124.6 million ($91.3 million)
Markets last week performed like a long-bedridden flu patient who finally broke their fever and started feeling fine enough to dance. Multiple catalysts contributed
Bitcoin and other cryptocurrencies were little changed Monday, holding at elevated levels after a recent rally as digital assets benefited from bets that the